Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease b-cell lymphomas
Comorbidity C0019163|hepatitis b
Sentences 5
PubMedID- 25848698 We performed a retrospective study to analyse the characteristics and clinical outcomes of diffuse large b-cell lymphoma (dlbcl) patients with hepatitis b virus (hbv) infection and compare with those without hbv infection.
PubMedID- 20837949 Prospective analysis of hepatitis b virus reactivation in patients with diffuse large b-cell lymphoma after rituximab combination chemotherapy.
PubMedID- 26058465 This study aimed to assess hbv reactivation and hepatitis occurrence in diffuse large b-cell lymphoma (dlbcl) patients with resolved hepatitis b receiving rituximab-containing chemotherapy compared with hbsag-negative/hbcab-negative patients to identify risk factors for hbv reactivation and hepatitis occurrence and to analyze whether hbv reactivation and hepatitis affect the survival of dlbcl patients with resolved hepatitis b.
PubMedID- 22432084 The association of hepatitis b virus infection with b-cell non-hodgkin lymphoma - a review.
PubMedID- 22029053 "prospective analysis of hepatitis b virus reactivation in patients with diffuse large b-cell lymphoma after rituximab combination chemotherapy".

Page: 1